INTRODUCTION

5
GSK-3β is an isoform of GSK-3, which was initially identified as an enzyme that negatively regulates the activity of glycogen synthase (Cohen, 1985) . Recently, GSK-3 has been discovered to be involved in the regulation of growth and development, mostly because the activation of this enzyme contributes to pro-apoptotic signaling. Lithium, an inhibitor of GSK-3, was found to protect cultured neurons against glutamate-induced apoptosis in a phosphatidyl-inositol-3-kinase (PI-3K)-dependent manner (Shimomura et al., 2003) . Moreover, recently it has been demonstrated that lithium in combination with chondroitinase ABC, improve the regenerative response after CNS injury and enhances the recovery of forelimb function compared with a single application of ChABC alone (Yick et al., 2004) . A large body of evidence supports the hypothesis that pharmacological inhibitors of GSK-3 could be used to treat several diseases, including Alzheimer's disease and other neurodegenerative diseases. More than 30 inhibitors of GSK-3 have been identified. Seven of these have been co-crystallized with GSK-3β and all localize within the ATPbinding pocket of the enzyme. GSK-3, as part of a multi-protein complex that contains proteins such as axin, presenilin and beta-catenin, contains many additional target sites for specific modulation of its activity.
In this study, we used the GSK-3β inhibitor 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) to investigate the role of this kinase in the modulation of secondary injury in the spinal cord. In particular, we have determined the following endpoints of the inflammatory response: (1) histological damage, (2) motor recovery, (3) neutrophil infiltration, (4) NF-κB expression, (5) nitrotyrosine, iNOS and COX-2 expression, (6) apoptosis (TUNEL staining), (7) Bax and Bcl-2 expression.
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Spinal cord injury (SCI)
Mice were anesthetized using chloral hydrate (400 mg/kg body weight). A longitudinal incision was made on the midline of the back, exposing the paravertebral muscles. These muscles were dissected away exposing T5-T8 vertebrae. The spinal cord was exposed via a four-level T6-T7 laminectomy and SCI was produced by extradural compression of the spinal cord using an aneurysm clip with a closing force of 24 g. In all injured groups, the spinal cord was compressed for 1 min. Sham animals were only subjected to laminectomy. Following surgery, 1.0 cc of saline was administered subcutaneously in order to replace the blood volume lost during the surgery.
During recovery from anesthesia, the mice were placed on a warm heating pad and covered with a warm towel. The mice were individually housed in a temperature-controlled room at 27°C for a survival period of 10 days. Food and water were provided to the mice ad libitum. During this time period, the animals' bladders were manually voided twice a day until the mice were able to regain normal bladder function.
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JPET Fast Forward. Published on April 6, 2006 as DOI: 10.1124 Ten mice from each group were sacrificed at different time points (see figure 1) in order to collect samples for the evaluation of the parameters as described below. In the experiments investigating the motor score, the animals were treated with 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) or with 3-[(3-Chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione (SB415286) (1 mg/kg 10% DMSO) 1 h prior, 3 and 6 h after SCI and daily until day 9.
Preparation of extracts of whole spinal cord
All the extraction procedures were performed on ice using ice-cold reagents. Spinal cord tissues from each mouse were suspended in 6 ml of a high-salt extraction buffer (20 mM pH 7.9 HEPES, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM Ethylenediaminetetraacetic acid (EDTA), 25% glycerol, 0.5 mM phenylmethylsulphonylfluoride, 1.5 µg/ml soybean trypsin inhibitor, 7 µg/ml pepstatin A, 5 µg/ml leupeptin, 0.1 mM benzamidine, 0.5 mM dithiothreitol) and homogenized at the highest setting for 2 min in a Polytron PT 3000 tissue homogenizer. The homogenates were chilled on ice for 15 min and then vigorously shaken for few minutes in the presence of 20 µl of 10% Nonidet P-40. The pellets were suspended in the supplied complete lysis buffer containing 10mM dithiothreitol, lysed for 30 min on ice and then centrifuged (10 min, 14,000 x g) to yield the nuclear fraction.
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This article has not been copyedited and formatted. The final version may differ from this version. The levels of IκB-α, phospho-NF-κB p65 (serine 536), Bax and Bcl-2 were quantified in whole extracts 24 h after SCI by Western blot analysis. Proteins were transferred onto nitrocellulose membranes, according to the manufacturer's instructions. Briefly, the membranes were saturated by incubation at room temperature for 1 hr with 10 % (w/v) non-fat dry milk in PBS and then incubated overnight at 4°C with anti-IκB-α (1:1000) or anti-Bax (1:100) or anti-Bcl-2 (1:100) or anti phospho-NF-κB p65 (serine 536) (1:1000). Nuclear fractions were incubated with anti-NF-kB p65 (1:1000; Santa Cruz, DBA, Milan, Italy). Membranes were washed three times with 1% (w/v) Tween 20 in PBS and then incubated with peroxidase-conjugated bovine anti-mouse IgG secondary antibody or perpxidase-conjugated goat anti-rabbit igG (1:2000, Jackson ImmunoResearch, West
Grove, PA) for 1 h at room temperature. The immune complexes were visualized using the SuperSignal West Pico chemiluminescence Substrate (PIERCE, Milan, Italy.) . Subsequently, the relative expression of the proteins was quantified by densitometric scanning of the X-ray films with GS-700 Imaging Densitometer (Bio-Rad) and a computer program (Molecular Analyst, IBM).
Electrophoretic mobility-shift assay (EMSA)
Double-stranded oligonucleotides containing the NF-κB recognition sequence (5'-GAT CGA GGG GAC TTT CCC TAG-3') were end labeled with γ-[ 
Myeloperoxidase activity
Twentyfour hours after SCI myeloperoxidase (MPO) activity, an indicator of polymorphonuclear leukocyte (PMN) accumulation, was determined as previously described (Mullane et al., 1985) . At the specified time following SCI, spinal cord tissues were obtained and weighed and each piece homogenized in a solution containing 0.5 % (w/v) hexadecyltrimethylammonium bromide dissolved in 10 mM potassium phosphate buffer (pH 7) and centrifuged for 30 min at 20,000 x g at 4°C. An aliquot of the supernatant was then allowed to react with a solution of 1.6 mM tetramethylbenzidine and 0.1 mM H 2 O 2 . The rate of change in absorbance was measured spectrophotometrically at 650 nm. MPO activity was defined as the quantity of enzyme degrading 1 µmol of peroxide per min at 37°C and was expressed in milliunits/g of wet tissue.
Immunohistochemical localization of nitrotyrosine, iNOS, COX-2, Bax and Bcl-2
At the 24 h after SCI, the tissues were fixed in 10% (w/v) PBS-buffered formaldehyde and 8 mm sections were prepared from paraffin embedded tissues. After deparaffinisation, endogenous peroxidase was quenched with 0.3% (v/v) hydrogen peroxide in 60% (v/v) methanol for 30 min.
The sections were permeabilized with 0.1% (w/v) Triton X-100 in PBS for 20 min. Non-specific
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Terminal Deoxynucleotidyltransferase-Mediated UTP End Labeling (TUNEL) Assay.
TUNEL assay was conducted by using a TUNEL detection kit according to the manufacturer's instructions (Apotag, HRP kit DBA, Milano, Italy). Briefly, sections were incubated with 15 µg/ml proteinase K for 15 min at room temperature and then washed with PBS. 
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Grading of motor disturbance
The motor function of mice subjected to compression trauma was assessed daily for 10 days after injury. Recovery from motor disturbance was graded using the modified murine Basso, Beattie, and Bresnahan (BBB) (Basso et al., 1995) hind limb locomotor rating scale (Joshi and Fehlings, 2002a,b) .
Materials
Unless otherwise stated, all compounds were obtained from Sigma-Aldrich Company Ltd.
(Milan, Italy). TDZD-8 was obtained from Axxora Corporation (Bingham, Nottingham, UK). (All stock solutions were prepared in non-pyrogenic saline (0.9% NaCl; Baxter, Italy) or 10% DMSO.
Statistical evaluation
All values in the figures and text are expressed as mean ± standard error of the mean (SEM) of N observations. For the in vivo studies N represents the number of animals studied. In the experiments involving histology or immunohistochemistry, the figures shown are representative of at least three experiments performed on different experimental days. The results were analyzed by one-way ANOVA followed by a Bonferroni post-hoc test for multiple comparisons. A p-value of
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Results
TDZD-8 reduces the severity of spinal cord trauma
The severity of the trauma at the level of the perilesional area, assessed as the presence of edema as well as alteration of the white matter (Figure 2b) , was evaluated at 24 h after injury. A significant damage to the spinal cord was observed in the spinal cord tissue of control mice subjected to SCI when compared with sham-operated mice (Figure 2a) . Notably, a significant protection against the spinal cord injury was observed in TDZD-8 treated mice (Figure 2c) . Myelin structure was detected by Luxol fast blue staining (Figure 2d,e,f) . In sham animals (Figure 2d ), myelin structure was clearly stained by Luxol fast blue in both lateral and dorsal funiculi of the spinal cord. At 24 h after the injury, a significant loss of myelin in lateral and dorsal funiculi was observed in control mice subjected to SCI (Figure 2e ). In contrast, in TDZD-8 treated mice myelin degradation was attenuated in the central part of lateral (Figure 2f ) and dorsal funiculi. In order to evaluate if histological damage to the spinal cord was associated with a loss of motor function, the modified BBB hind limb locomotor rating scale score was evaluated. While motor function was only slightly impaired in sham mice, mice subjected to SCI had significant deficits in hind limb movement (Figure 3) . A significant amelioration of hind limb motor disturbances was observed in TDZD-8 treated mice (Figure 3) . In addition, in order to confirm that the protective effects of TDZD-8 on motor function are related to the GSK-3β, we have also investigated whether SB415286, an other GSK-3β selective inhibitor, attenuates the motor dysfunction induced by SCI. As shown in Figure   3 also the treatment with SB415286 significantly leads to an amelioration of hind limb motor disturbances. Please note that No significant difference was found between the TDZD-8 or SB415286 treatment (Figure 3) .
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Effects of TDZD-8 on neutrophil infiltration
The abovementioned histological pattern of spinal cord injury appeared to be correlated with the influx of leukocytes into the spinal cord. Therefore, we investigated the role of TDZD-8 on the neutrophil infiltration by measuring tissue myeloperoxidase (MPO) activity. MPO activity was significantly elevated in the spinal cord at 24 h after injury in control mice subjected to SCI when compared with sham-operated mice (Figure 4) . In TDZD-8 treated mice, the MPO activity in the spinal cord at 24 h after injury was significantly attenuated in comparison to that observed in SCI controls (Figure 4) .
TDZD-8 modulates expression of nitrotyrosine, iNOS and COX-2 after SCI
Twenty-four h after SCI, nitrotyrosine, a specific marker of nitrosative stress, was measured by immunohistochemical analysis in the spinal cord sections, to determine the localization of "peroxynitrite formation" and/or other nitrogen derivatives produced during SCI.
Immunohistological staining for iNOS and COX-2 in the spinal cord was also determined 24 h after injury. Sections of spinal cord from sham-operated mice did not stain for nitrotyrosine, iNOS, or COX-2 (data not shown), whereas spinal cord sections obtained from SCI control mice exhibited positive staining for iNOS (Figures 5a, 6 ), nitrotyrosine (Figures 5c, 6 ) and COX-2 (Figures 5e,   6 ). The positive staining was localized in various cells in the gray matter. TDZD-8 treatment (1 h before and 3 and 6 h after SCI induction) of mice subjected to SCI reduced the degree of positive staining for iNOS (Figures 5b, 6 ), nitrotyrosine (Figures 5d, 6 ) and COX-2 (Figures 5f, 6 ) in the spinal cord.
Effect of TDZD-8 on IκB-α degradation, phosphorylation of Ser536 on p65, expression of NF-κB p65 and NF-κB translocation.
By Western Blot analysis and translocation of NF-κB, one of the major transcription factors involved in the signal transduction of inflammation (La Rosa et al., 2004) , we evaluated both IκB-α
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IκB-α appearance in the spinal cord homogenates was investigated by immunoblot analysis at 24 h after SCI. A basal level of IκB-α was detected in the spinal cord from sham-operated animals (Figure 7a,a1) , whereas in SCI control mice IκB-α levels were substantially reduced (Figure   7a,a1) . TDZD-8 prevented the SCI-induced IκB-α degradation and the IκB-α expression remained unchanged 24 h after SCI in TDZD-8 treated mice (Figure 7a,a1) . In addition, SCI caused a significant increase in the phosphorylation of Ser536 at 24 h (Figure 7b,b1) . The treatment with the GSK-3β inhibitor TDZD-8 significantly reduced the phosphorylation of p65 on Ser536 (Figure   7b,b1) . Moreover, the levels of the NF-kB p65 subunit protein in the nuclear fractions of the spinal cord tissue were also significantly increased at 24h after SCI compared to the sham-operated mice (Figure 7c,c1) . TDZD-8 treatment significantly reduced the levels of NF-kB p65 protein as shown in Figure 7c ,c1. To detect NF-κB/DNA binding activity, whole extracts of spinal cord from each mouse were analyzed by EMSA. A low basal level of NF-κB/DNA binding activity was detected in tissue from sham-operated mice (Figure 8a,a1) . 24 h after SCI, the DNA binding activity was significantly increased in whole extracts obtained from vehicle-treated SCI control mice (Figure   8a,a1) . Treatment of mice with TDZD-8 caused a significant inhibition of SCI-induced NF-κB/DNA binding activity as revealed by EMSA (Figure 8a,a1) . The specificity of NF-κB/DNA binding complex was demonstrated by the complete displacement of the NF-κB/DNA binding in the presence of a 50-fold molar excess of unlabeled NF-κB probe (W.T. 50x) in the competition reaction. In contrast a 50-fold molar excess of unlabeled mutated NF-κB probe (Mut. 50x) or Sp-1 oligonucleotide (Sp-1 50x) had no effect on this DNA-binding activity (data not shown).
This article has not been copyedited and formatted. The final version may differ from this version. (Figure 9a, a1) . In contrast, tissues obtained from mice treated with TDZD-8 (Figure 9b ) demonstrated a small number of apoptotic cells or fragments.
Western blot analysis and immunohistochemistry for Bax and Bcl-2
At 24 h after SCI the appearance of Bax in spinal cord homogenates was investigated by Western blot. A basal level of Bax was detected in the spinal cord from sham-operated animals (Figure 10a,a1) . Bax levels were appreciably increased in the spinal cord from control mice subjected to SCI (Figure 10 a,a1) . On the contrary, TDZD-8 treatment (1 h prior and 3 and 6 h after SCI induction) prevented the SCI-induced Bax expression (Figure 10 a,a1) By Western blot analysis were also analyzed whole extracts from spinal cord of each mice to detect Bcl-2 expression . A low basal level of Bcl-2 expression was detected in spinal cord from sham-operated mice (Figure 10b,b1) . 24 h after SCI, the Bcl-2 expression was significantly reduced in whole extracts obtained from spinal cord of SCI control mice (Figure 10b,b1) .
Treatment of mice with TDZD-8 (1 h prior and 3 and 6 h after SCI induction) significantly reduced the SCI-induced inhibition of Bcl-2 expression (Figure 10b,b1) .
Moreover, samples of spinal cord tissue were taken at 24 h after SCI in order to determine the immunohistological staining for Bax and Bcl-2. Sections of spinal cord from sham-operated mice did not stain for Bax (Figure 11a ) whereas spinal cord sections obtained from SCI control mice exhibited a positive staining for Bax (Figure 11b) . TDZD-8 treatment reduced the degree of positive staining for Bax in the spinal cord of mice subjected to SCI (Figure 11c ).
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TDZD-8 treatment attenuated the loss of positive staining for Bcl-2 in the spinal cord from SCIsubjected mice (Figure 11f ).
GSK-3β inhibitor, reduced (1) the degree of spinal cord damage, (2) neutrophils infiltration, (3) NF-
κB/DNA binding, (4) IκB-α degradation, (5) expression of iNOS, nitrotyrosine, and COX-2, and (6) apoptosis.
GSK-3β role in the regulation of spinal cord injury is of special interest because several transcription factors important to the regulation of secondary damage serve as substrates for GSK-3β. Among these is the transcription factor NF-κB, whose function is strikingly altered by GSK-3β (Hoeflich et al., 2000; Buss et al., 2004) . NF-κB plays a central role in the regulation of many genes responsible for the generation of mediators or proteins in inflammation. These include the genes for TNF-α, IL-1β, iNOS and COX-2, to name but a few (Verma , 2004) . The discovery in 1997 that inhibition of the NF-κB activation may be useful in conditions associated to local or systemic inflammation (Ruetten and Thiemermann, 1997 ) stimulated the search for agents which prevent the activation of NF-κB. The extent to which GSK-3β activates or blocks NF-κB signaling remains unclear. In 2000 Hoeflich and colleagues first demonstrated that deletion of GSK-3β had no effect
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This article has not been copyedited and formatted. The final version may differ from this version. on the TNF-α-induced IκB-α degradation or on the nuclear translocation of the subunit p65, but prevented the activation of NF-κB by an unknown mechanism (Hoeflich et al., 2000) . On the other hand, other studies provided evidence for an inverse association between GSK-3β activity and NF-κB signaling. Sanchez and colleagues reported that over-expression of GSK-3β in astrocytes was associated to the inhibition of NF-κB activation (Sanchez et al., 2003) . Another recent report
showed that GSK-3β-dependent phosphorylation of a specific serine residue (Ser468) on p65 blocks the activation of NF-κB and that inhibition of GSK-3β was related to increased p65 activity (Buss et al., 2004) . We report here that SCI caused a significant increase in the phosphorylation of Ser536 on p65 in the spinal cord tissues at 24 h, whereas GSK-3β inhibitor TDZD-8 treatment significantly reduced this phosphorylation. Moreover, we also demonstrate that selective and potent GSK-3β inhibitor TDZD-8, inhibited the IκB-α degradation as well as the NF-κB translocation.
Taken together, the balance between pro-inflammatory and pro-survival roles of NF-κB may depend on the phosphorylation status of p65, and GSK-3β may play a central role in this process.
However, the reasons for the apparent discrepancies in the modulatory effects of GSK-3β on NF-κB activity remain to be fully clarified. In the pathological processes of acute SCI the up-regulation of COX-2, a key enzyme in the synthesis of prostaglandins (PGs), has also been proposed to be involved. It is known that COX-1 and COX-2 mRNA and protein are present in the spinal cord tissue and that COX-2 protein is expressed in white matter astrocytes during basal conditions (Beiche et al., 1998) . In particular, COX-2 has been found in neurons of all laminae and in the white matter glial cells. Many conditions in which inflammation and pain play an important role are associated to COX-2 expression which may be widespread (Vanegas and Schaible, 2001 ). Rao and colleagues have recently shown that the inhibition of GSK-3β leads to an activation of COX-2 via induction of NF-κB-dependent pathways (Rao et al., 2004) . However, it has been also demonstrated that inhibition of GSK-3β down-regulates the expression of COX-2, induced by TNF or hypertonic stress, in cells via the induction of a NF-κB-COX-2 dependent pathway (Rao et al., 2004) . The
This article has not been copyedited and formatted. The final version may differ from this version. result of this study are in accordance with the latter study, by demonstrating that the increase of COX-2 expression is reduced in the spinal cord from mice subjected to SCI and treated with TDZD-8. COX-2 is one of the genes regulated by NF-κB and there is good evidence that an enhanced formation of prostanoids following COX-2 induction contributes to the pathophysiology of inflammation as well as in this and in other models of inflammation (Malmberg and Yaksh, 1995) .
It has also been demonstrated that an enhanced formation of NO by iNOS contributes to the inflammatory process (Vanegas and Schaible, 2001; Abramson et al., 2001 ). This study demonstrates that TDZD-8 attenuates the expression of iNOS in the tissue from SCI treated mice when compared with SCI+vehicle operated mice. Therefore, the inhibition of both COX-2 and iNOS expression by TDZD-8 described in the present study is likely to be due to the inhibition of NF-κB activation by TDZD-8 mediated by GSK-3β. Furthermore, we have found that the tissue damage induced by SCI in SCI+vehicle operated mice was associated to an intense immunostaining of nitrotyrosine formation that suggests that a alteration of the tissue had also occurred, due to the formation of highly reactive nitrogen-derivatives. Peroxynitrite, one of a number of toxic factors produced in the spinal cord tissues after SCI (Xu et al., 2001) , likely contributes to secondary neuronal damage through pathways resulting from the chemical modification of cellular proteins and lipids. Nitrotyrosine formation, along with its detection by immunostaining, was initially proposed as a relatively specific marker for the detection of the endogenous formation "footprint" of peroxynitrite (Beckman, 1996) . There is, however, recent evidence that certain other reactions can also induce tyrosine nitration; e.g., the reaction of nitrite with hypochlorous acid and the reaction of myeloperoxidase with hydrogen peroxide can lead to the formation of nitrotyrosine (Endoh et al., 1994) . Increased nitrotyrosine staining is considered, therefore, as an indication of "increased nitrosative stress" rather than a specific marker of the peroxynitrite generation. There is a large amount of evidence that implicated ROS in the secondary neuronal damage of spinal cord injury (SCI) (Xu et al., 2001 ). Generation of free radicals and nitric
This article has not been copyedited and formatted. The final version may differ from this version. oxide by activated macrophages has also been implicated in causing oligodendrocyte apoptosis (Merrill et al., 1993) . In an effort to prevent or diminish levels of apoptosis, we have demonstrates that the treatment with TDZD-8 attenuates the degree of apoptosis, measured by TUNEL detection kit, in the spinal cord after the damage. There is evidence that direct overexpression of GSK-3β is known to induce apoptosis in neuronal cells in culture, and specific inhibitors of GSK-3β are able to ameliorate this apoptotic response (Pap and Cooper, 1998) . Recent studies from our laboratory have
shown that up-regulation of GSK-3β activity can also lead to cell death and aberrant neuronal migration in primary neuronal populations (Tong et al., 2001 ). Dong and colleagues, used Wld s (Wallerian degeneration, slow) mice and Bax-deficient (Bax-/-) mice in a lateral cord hemisection model of SCI to test the hypothesis that the protracted wave of apoptotic death of oligodendrocytes may be dependent on axonal degeneration and Bax activation (Dong et al., 2003) . The Bax gene plays an important role in developmental cell death (Chittenden et al., 1995) and in CNS injury (Bar-Peled et al., 1999) . Apoptosis and the neuronal cell loss that occurs during normal nervous system development and in response to trophic factor deprivation is attenuated in Bax-/-mice (Deckwerth et al., 1996) . Nesic-Taylor and colleagues showed that administering Bcl-xL fusion protein (Bcl-xL FP, the most robustly expressed antiapoptotic Bcl-2 molecule in adult central nervous system) into injured spinal cords significantly increased neuronal survival, suggesting that SCI-induced changes in Bcl-xL contribute considerably to neuronal death. Because Bcl-xL FP increases survival of dorsal horn neurons and ventral horn motoneurons, it could become clinically relevant in preserving sensory and motor functions after SCI (Nesic-Taylor et al., 2005) . It's known that pathways which inhibit GSK-3β activity, such as PI-3K or Wnt signaling, often lead to the induction of the nuclear factor kB (NF-kB) cell survival pathway (Bournat et al., 2000) . Indeed, GSK-3β is a major target of Akt/PKB (van Weeren et al., 1998) , which is activated by the PI-3K mediated signaling pathway. Cellular factors which have implicated in the regulation of astrocyte apoptosis include PI-3K pathway . Inhibition of this signaling cascade has been
shown to lead to cell death in several paradigms (Carbott et al., 2002) , and this has been attributed,
This article has not been copyedited and formatted. The final version may differ from this version. A basal level of IκB-α was detected in the spinal cord from sham-operated animals (a,a1), whereas in SCI control mice IκB-α levels were substantially reduced (a,a1). TDZD-8 prevented the SCIinduced IκB-α degradation and the IκB-α band remained unchanged 24 h after SCI in TDZD-8 treated mice (a,a1). In addition, SCI caused a significant increase in the phosphorylation of Ser536 at 24 h (b,b1). The treatment with the GSK-3β inhibitor TDZD-8 significantly reduced the phosphorylation of p65 on Ser536 (b,b1). Moreover, the levels of the NF-kB p65 subunit protein in the nuclear fractions of the spinal cord tissue were also significant increased at 24h after SCI
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